SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases

NCT06210438 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

TNBC
Brain Metastasis

Interventions

DRUG: SHR-A1921 + Bevacizumab

Sponsor

Fudan University